In this episode, I share my top five predictions for 2023 in the field of ophthalmology. Brought to you by Alcon <ul> <li>Welcome to another exciting episode of Eye Care insider :52</li> <li>My review of the top five predictions in ophthalmology 1:03</li> <li>Prediction #1 – Vabysmo and anti-VEGF market 1:53</li> <li>Prediction #2 – FDA approval for GA treatment 4:26</li> <li>Prediction #3 – <a href="http://www.snapseyeshield.com">SNAPS eye shield</a> for ocular protection 6:06</li> <li>Prediction #4 – biosimilars and the ophthalmic therapeutic marketplace 10:08</li> <li>Prediction #5 – retina analytical tools 12:27</li> <li>Thanks for listening 14:30</li> </ul> We'd love to hear from you! Send your comments/questions to Dr. Mali at <a href= "mailto:eyecareinsider@healio.com">eyecareinsider@healio.com</a>. Follow us on Twitter <a href= "https://twitter.com/HRheuminations">@Healio_OSN</a>. Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; consultant/speaker for Genentech and Roche; equity owner for SNAPS; and grant/consultant for RetinAI.

<description>&lt;p&gt;In this episode, I share my top five predictions for 2023 in the field of ophthalmology.&lt;/p&gt; &lt;p&gt;&lt;em&gt;Brought to you by Alcon&lt;/em&gt;&lt;/p&gt; &lt;ul&gt; &lt;li&gt;Welcome to another exciting episode of Eye Care insider &lt;strong&gt;&lt;em&gt;:52&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt; &lt;li&gt;My review of the top five predictions in ophthalmology &lt;strong&gt;&lt;em&gt;1:03&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt; &lt;li&gt;Prediction #1 – Vabysmo and anti-VEGF market &lt;strong&gt;&lt;em&gt;1:53&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt; &lt;li&gt;Prediction #2 – FDA approval for GA treatment &lt;strong&gt;&lt;em&gt;4:26&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt; &lt;li&gt;Prediction #3 – &lt;a href="http://www.snapseyeshield.com"&gt;SNAPS eye shield&lt;/a&gt; for ocular protection &lt;strong&gt;&lt;em&gt;6:06&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt; &lt;li&gt;Prediction #4 – biosimilars and the ophthalmic therapeutic marketplace &lt;strong&gt;&lt;em&gt;10:08&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt; &lt;li&gt;Prediction #5 – retina analytical tools &lt;strong&gt;&lt;em&gt;12:27&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt; &lt;li&gt;Thanks for listening &lt;strong&gt;&lt;em&gt;14:30&lt;/em&gt;&lt;/strong&gt;&lt;/li&gt; &lt;/ul&gt; &lt;p&gt;We'd love to hear from you! Send your comments/questions to Dr. Mali at &lt;a href= "mailto:eyecareinsider@healio.com"&gt;eyecareinsider@healio.com&lt;/a&gt;. Follow us on Twitter &lt;a href= "https://twitter.com/HRheuminations"&gt;@Healio_OSN&lt;/a&gt;.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Disclosures:&lt;/strong&gt; Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; consultant/speaker for Genentech and Roche; equity owner for SNAPS; and grant/consultant for RetinAI.&lt;/p&gt;</description>

Dr. Mali's Top 5 Predictions in Ophthalmology for 2023

Description